EARNEST Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-39
| Closed | -$14.6K | – | 1104 |
|
|
2023
Q3 | $14.6K | Hold |
39
| – | – | ﹤0.01% | 552 |
|
|
2023
Q2 | $14.9K | Hold |
39
| – | – | ﹤0.01% | 545 |
|
|
2023
Q1 | $13.5K | Hold |
39
| – | – | ﹤0.01% | 557 |
|
|
2022
Q4 | $9.18K | Hold |
39
| – | – | ﹤0.01% | 637 |
|
|
2022
Q3 | $10K | Hold |
39
| – | – | ﹤0.01% | 597 |
|
|
2022
Q2 | $12K | Hold |
39
| – | – | ﹤0.01% | 569 |
|
|
2022
Q1 | $16K | Hold |
39
| – | – | ﹤0.01% | 543 |
|
|
2021
Q4 | $18K | Hold |
39
| – | – | ﹤0.01% | 530 |
|
|
2021
Q3 | $17K | Hold |
39
| – | – | ﹤0.01% | 529 |
|
|
2021
Q2 | $14K | Hold |
39
| – | – | ﹤0.01% | 575 |
|
|
2021
Q1 | $11K | Hold |
39
| – | – | ﹤0.01% | 616 |
|
|
2020
Q4 | $11K | Hold |
39
| – | – | ﹤0.01% | 596 |
|
|
2020
Q3 | $11K | Hold |
39
| – | – | ﹤0.01% | 546 |
|
|
2020
Q2 | $9K | Hold |
39
| – | – | ﹤0.01% | 596 |
|
|
2020
Q1 | $6K | Hold |
39
| – | – | ﹤0.01% | 639 |
|
|
2019
Q4 | $6K | Buy |
+39
| New | +$6K | ﹤0.01% | 744 |
|
|
2018
Q4 | – | Sell |
-20
| Closed | -$2K | – | 1220 |
|
|
2018
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 1053 |
|
|
2018
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 1062 |
|
|
2018
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 1032 |
|
|
2017
Q4 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 1032 |
|
|
2017
Q1 | – | Sell |
-20
| Closed | -$2K | – | 915 |
|
|
2016
Q4 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 975 |
|